Cargando…
Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq
BACKGROUND: In patients with rheumatoid arthritis (RA), hematological indices and ratios have been reported to be related to the severity of illness, and thus could potentially be useful determinants of quality of life (QoL). OBJECTIVE: To evaluate the association between hematological indices or ra...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211417/ https://www.ncbi.nlm.nih.gov/pubmed/37252022 http://dx.doi.org/10.4103/sjmms.sjmms_517_22 |
_version_ | 1785047270890143744 |
---|---|
author | Aref, Sheelan Faroz Jalal, Aryan Mohamadfatih Mawlood, Zhala Kakamin Al-Nimer, Marwan Salih |
author_facet | Aref, Sheelan Faroz Jalal, Aryan Mohamadfatih Mawlood, Zhala Kakamin Al-Nimer, Marwan Salih |
author_sort | Aref, Sheelan Faroz |
collection | PubMed |
description | BACKGROUND: In patients with rheumatoid arthritis (RA), hematological indices and ratios have been reported to be related to the severity of illness, and thus could potentially be useful determinants of quality of life (QoL). OBJECTIVE: To evaluate the association between hematological indices or ratios, which serve as biomarkers of disease activity, and the QoL of RA patients. MATERIALS AND METHODS: This study was carried out in the Rizgary Teaching Hospital in the Kurdistan region of Iraq between December 01, 2021, and March 31, 2022. All female patients with a confirmed diagnosis of RA and aged ≥18 years were included. Data relating to the disease activity score (DAS-28), biochemical measurements of the profile, and hematological indices and ratios were assessed. The QoL of each patient was assessed using the Quality of Life-Rheumatoid Arthritis II (QoL-RA II) and the World Health Organization-Quality of Life (WHOQOL-BREF) scales. RESULTS: A total of 81 participants were included, with a median disease duration of 9 years. The median values of the hematological indices were as follows: mean corpuscular volume, 80 fL; platelet count 282 × 10(3)/mm(3); mean platelet volume, 9.7 fL; neutrophil-to-lymphocyte ratio, 2.76; and platelet-to-lymphocyte ratio, 170.5. In six of the eight domains of the QoL-RA II scale, the median score was ≤5, indicating poor QoL. The transformed scores of WHOQOL-BREF domains were <50. Multivariate regression analysis showed significant inverse correlations between plateletcrit and the health domains. The area under the curve of the physical, psychological, and environmental domains was <0.5 at a cutoff value of plateletcrit of 0.25. CONCLUSIONS: In RA patients, hematological indices and ratios could serve as a QoL assessment tool, particularly plateletcrit, as higher plateletcrit (≥0.25) were found to negatively impact the physical health, psychological, and environmental domains. |
format | Online Article Text |
id | pubmed-10211417 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-102114172023-05-26 Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq Aref, Sheelan Faroz Jalal, Aryan Mohamadfatih Mawlood, Zhala Kakamin Al-Nimer, Marwan Salih Saudi J Med Med Sci Original Article BACKGROUND: In patients with rheumatoid arthritis (RA), hematological indices and ratios have been reported to be related to the severity of illness, and thus could potentially be useful determinants of quality of life (QoL). OBJECTIVE: To evaluate the association between hematological indices or ratios, which serve as biomarkers of disease activity, and the QoL of RA patients. MATERIALS AND METHODS: This study was carried out in the Rizgary Teaching Hospital in the Kurdistan region of Iraq between December 01, 2021, and March 31, 2022. All female patients with a confirmed diagnosis of RA and aged ≥18 years were included. Data relating to the disease activity score (DAS-28), biochemical measurements of the profile, and hematological indices and ratios were assessed. The QoL of each patient was assessed using the Quality of Life-Rheumatoid Arthritis II (QoL-RA II) and the World Health Organization-Quality of Life (WHOQOL-BREF) scales. RESULTS: A total of 81 participants were included, with a median disease duration of 9 years. The median values of the hematological indices were as follows: mean corpuscular volume, 80 fL; platelet count 282 × 10(3)/mm(3); mean platelet volume, 9.7 fL; neutrophil-to-lymphocyte ratio, 2.76; and platelet-to-lymphocyte ratio, 170.5. In six of the eight domains of the QoL-RA II scale, the median score was ≤5, indicating poor QoL. The transformed scores of WHOQOL-BREF domains were <50. Multivariate regression analysis showed significant inverse correlations between plateletcrit and the health domains. The area under the curve of the physical, psychological, and environmental domains was <0.5 at a cutoff value of plateletcrit of 0.25. CONCLUSIONS: In RA patients, hematological indices and ratios could serve as a QoL assessment tool, particularly plateletcrit, as higher plateletcrit (≥0.25) were found to negatively impact the physical health, psychological, and environmental domains. Wolters Kluwer - Medknow 2023 2023-04-19 /pmc/articles/PMC10211417/ /pubmed/37252022 http://dx.doi.org/10.4103/sjmms.sjmms_517_22 Text en Copyright: © 2023 Saudi Journal of Medicine & Medical Sciences https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Aref, Sheelan Faroz Jalal, Aryan Mohamadfatih Mawlood, Zhala Kakamin Al-Nimer, Marwan Salih Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq |
title | Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq |
title_full | Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq |
title_fullStr | Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq |
title_full_unstemmed | Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq |
title_short | Plateletcrit is a Useful Marker in the Quality of Life Assessment of Patients with Rheumatoid Arthritis: A Cross-Sectional Study from Erbil, Iraq |
title_sort | plateletcrit is a useful marker in the quality of life assessment of patients with rheumatoid arthritis: a cross-sectional study from erbil, iraq |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10211417/ https://www.ncbi.nlm.nih.gov/pubmed/37252022 http://dx.doi.org/10.4103/sjmms.sjmms_517_22 |
work_keys_str_mv | AT arefsheelanfaroz plateletcritisausefulmarkerinthequalityoflifeassessmentofpatientswithrheumatoidarthritisacrosssectionalstudyfromerbiliraq AT jalalaryanmohamadfatih plateletcritisausefulmarkerinthequalityoflifeassessmentofpatientswithrheumatoidarthritisacrosssectionalstudyfromerbiliraq AT mawloodzhalakakamin plateletcritisausefulmarkerinthequalityoflifeassessmentofpatientswithrheumatoidarthritisacrosssectionalstudyfromerbiliraq AT alnimermarwansalih plateletcritisausefulmarkerinthequalityoflifeassessmentofpatientswithrheumatoidarthritisacrosssectionalstudyfromerbiliraq |